GUJARAT KIDNEY & S...● IPO DETAIL GMP+₹3 STATUSListed IPOCloudTrack Every IPO GUJARAT KIDNEY & S...● IPO DETAIL GMP+₹3 STATUSListed IPOCloudTrack Every IPO
Live GMP
Back to IPOs
Gujarat Kidney & Super Speciality Ltd.

Gujarat Kidney & Super Speciality Ltd.

NSE & BSE · Mainboard IPO
Listed NSE & BSE Mainboard Live Chart
Issue Price
₹114
₹114
GMP (Grey Market)
+₹3
+2.63%
Est. Listing Price
₹117
Based on GMP
Min. Investment
₹14,592
1 lot × 128 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
22 Dec 2025
Close Date
24 Dec 2025
Allotment
26 Dec 2025
Listing Date
30 Dec 2025
Exchange
NSE & BSE
Price Band
₹114
Listing Price
See chart
Allotment Status
Price Band
₹114
Per share
Face Value
₹2 per share
 
Lot Size
128 Shares
per lot
Issue Size
2,20,00,000 shares (aggregating up to ₹[.] Cr
Total offering
Issue Type
Book Built Issue
 
Min Investment
₹14,592
1 lot
Pre-IPO Holding
5,68,43,250 shares
Promoters
Post-IPO Holding
7,88,43,250 shares
Promoters
P/E (Pre)
61.62x
 
P/E (Post)
41.59x
 
EPS (Pre)
₹1.85
 
EPS (Post)
₹2.74
 
UPI Deadline
2025-12-24
Mandate
GMP
+₹3
+2.63% est.
Anchor AllotmentFri, 19 Dec 2025
Basis of AllotmentFri, 26 Dec 2025
Refund InitiationMon, 29 Dec 2025
Demat CreditMon, 29 Dec 2025
Listing DayTue, 30 Dec 2025
UPI Mandate Deadline2025-12-24
Sale TypeFresh Capital
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Gujarat Kidney & Super Speciality Ltd. IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 24 Dec 2025.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
QIB
Over 1.00x
NII / HNI
Over 1.00x
Retail
Over 1.00x
Total 1.00x
22,000,000
100% ₹250.80
IPO Shares Offered
Gujarat Kidney & Super Speciality Ltd. IPO total issue size: ₹250.80 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Total 22,000,000 ₹250.80
100.00%
* Based on upper price band ₹114 per share
Lot Size & Investment
Lot Size
128
Shares per Lot
Issue Price
₹114.00
Upper Band
Min Investment
₹14,592
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)2256₹29,184
Retail (Max — 13 Lots)131,664₹189,696
S-HNI (Min — 14 Lots)141,792₹204,288
B-HNI (Min — 69 Lots)698,832₹1,006,848
* Issue Price ₹114 × Lot Size 128 shares
IPO Schedule
Anchor
19 Dec 2025
✓ Done
IPO Open
22 Dec 2025
✓ Done
IPO Close
24 Dec 2025
✓ Done
Allotment
26 Dec 2025
✓ Done
Refunds
29 Dec 2025
✓ Done
Demat Credit
29 Dec 2025
✓ Done
Listing Day
30 Dec 2025
✓ Done
Gujarat Kidney & Super Speciality Ltd. — Live Price LIVE
₹114.00
INR · BSE
Fetching…
vs Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹114.00 GMP: +₹3 Live Price
About Gujarat Kidney & Super Speciality Ltd.
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).Services:Secondary Care Services: General and surgical treatments. Tertiary Care Services: Super speciality surgical procedures. Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology.As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff.Competitive Strengths:Pre-eminence in renal sciences, with established sub-superspecialities in urologyAsset light business model with focus in central region of GujaratAbility to attract, retain skilled and experienced quality medical professionalsTrack record of operating and financial performance and growth
Objects of the Issue
1
Proposed acquisition of Parekhs Hospital at Ahmedabad.
2
Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”.
3
Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara.
4
Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location.
5
Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company
6
Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.
7
Acquisition of additional shareholding in the subsidiary namely “Harmony Medicare Private Limited” at Bharuch
Gujarat Kidney & Super Speciality Ltd. Financials (Amount in ₹ Crore)
Revenue from Operations
₹5.5
31 Mar 2024
₹40.4
31 Mar 2025
₹15.3
30 Jun 2025
Profit After Tax (PAT)
₹1.7
31 Mar 2024
₹9.5
31 Mar 2025
₹5.4
30 Jun 2025
Particulars30 Jun 202531 Mar 202531 Mar 2024
Revenue from Operations 15.27 40.40 5.48
EBITDA 8.63 16.55 1.95
Profit After Tax (PAT) 5.40 9.50 1.71
Net Worth 30.56 25.71 10.80
Total Assets 61.59 55.34 20.53
Reserves & Surplus 19.42 14.57 10.60
Borrowings 4.03 3.88 1.94
EBITDA Margin (%) 41.12
PAT Margin (%) 23.61
P/BV Ratio
22.62
RoE
36.61
RoCE
37.65
RoNW
36.61
PAT Margin
23.61
EBITDA Margin
41.12
Debt/Equity
0.15
Issue Structure & Shareholding
Total Shares Offered2,20,00,000 (100.00%)
Net Offer to PublicN/A
Reserved for Market MakerN/A
Pre-Issue Promoter Holding5,68,43,250 shares
Post-Issue Promoter Holding7,88,43,250 shares
P/BV Ratio22.62
RoE36.61
RoCE37.65
Debt / Equity0.15
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
Nirbhay Capital Services Pvt.Ltd.
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Gujarat Kidney & Super Speciality Ltd. IPO subscribed?

Gujarat Kidney & Super Speciality Ltd. IPO is subscribed 1.00 times by Dec 24, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Gujarat Kidney & Super Speciality Ltd. IPO retail subscription status?

The Gujarat Kidney & Super Speciality Ltd. IPO retail category is subscribed 1.00 times as of 24 Dec 2025. The retail portion is oversubscribed.

How to subscribe Gujarat Kidney & Super Speciality Ltd. IPO?

Subscribe via your broker app using ASBA or UPI. Opens 22 Dec 2025 and closes 24 Dec 2025. Min investment: ₹14,592 (1 lot = 128 shares). UPI mandate: 2025-12-24.

How many times Gujarat Kidney & Super Speciality Ltd. IPO subscribed?

The Gujarat Kidney & Super Speciality Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Gujarat Kidney & Super Speciality Ltd. IPO allotment?

Check allotment on the registrar website (MUFG Intime India Pvt.Ltd) at https://linkintime.co.in/Initial_Offer/public-issues.html. Enter your PAN, application number or DP/Client ID. Allotment date: 26 Dec 2025. Refunds: on 29 Dec 2025.

When Gujarat Kidney & Super Speciality Ltd. IPO will be listed?

The Gujarat Kidney & Super Speciality Ltd. IPO listing date is 30 Dec 2025, Tuesday. Listed on: NSE & BSE. Issue price: ₹114. Estimated listing: ₹117. GMP: +₹3.

When Gujarat Kidney & Super Speciality Ltd. IPO close?

The Gujarat Kidney & Super Speciality Ltd. IPO closes on 24 Dec 2025, Wednesday. UPI mandate: 2025-12-24. Allotment: 26 Dec 2025. Listing: 30 Dec 2025.